Results 271 to 280 of about 68,271 (373)

Establishment of a Protocol for CE‐MS Based Peptidome Analysis of Human Saliva

open access: yesPROTEOMICS, EarlyView.
ABSTRACT Proteins and peptides indicate physiological or pathological states and are investigated to identify markers to scrutinize health and disease surveillance. Saliva contains many proteins and peptides that could serve as biomarkers, offering a potential noninvasive approach for disease detection.
Carl‐Johan Törnhage   +6 more
wiley   +1 more source

Host-encoded DNA methyltransferases modify the epigenome and host tropism of invading phages. [PDF]

open access: yesiScience
Takahashi M   +9 more
europepmc   +1 more source

Glycoproteomics and Its Role in Understanding Bacterial O‐Linked Glycosylation

open access: yesPROTEOMICS, EarlyView.
ABSTRACT Protein glycosylation is now recognized as a ubiquitous process observed in all domains of life. Within bacterial species, carbohydrates can be attached to multiple residues with glycosylation of serine, threonine, or tyrosine residues via their hydroxyl side chains referred to as O‐linked glycosylation.
Kristian I. Karlic   +2 more
wiley   +1 more source

Characterising Dissolution Dynamics of Engineered Nanomaterials: Advances in Analytical Techniques and Safety‐by‐Design

open access: yesSmall, EarlyView.
The perspective highlights how advanced analytical and computational tools—from batch tests and isotope labeling to in situ Electron Microscopy and Artificial IntelligenceI/Machine Learning—enable a deeper understanding of Engineered nanomaterial dissolution. These insights are crucial for controlling, regulating, and leveraging dissolution dynamics to
Swaroop Chakraborty   +2 more
wiley   +1 more source

Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape

open access: yesSmall, EarlyView.
This review presents a detailed overview of clinically approved nanoparticle therapeutics, classifying them by type and discussing their unique advantages in drug delivery. It highlights regulatory challenges across global markets and emphasizes the need for adaptive approval pathways.
Nimeet Desai   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy